NTI 0.00% 5.9¢ neurotech international limited

Ann: Trading Halt, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,431 Posts.
    lightbulb Created with Sketch. 591


    Primary outcome [1] - Change in Clinical Global Impression Scale -Improvement (CGI-I)This is a 7-point scale measuring symptom change from baseline

    Primary outcome 2 - Change in Vineland Adaptive Behaviour Scales, Third Edition (Vineland-3) Parent/Caregiver Form.Used to measure adaptive functioning across three core domains (Communication, Daily Living Skills, and Socialization), and two optional domains (Motor Skills and Maladaptive Behaviour); items are rated on a 3-point scale (0=never; 1=sometimes; 2=usually or often). The core domains sum to a total Adaptive Behaviour Composite.

    There are Many secondary outcomes / measures. Very comprehensive so gives (me) an understanding of why it takes so long to compile the results and understand drivers for any outliers. There will be a cornucopia of other data collected against the above measures for other trials to compare to. Also blood as youve mentioned, liver and renal tests for safety.

    All the detail here: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381885&isReview=true although updating the CTR site isnt one of NTI or Fenix's strong points.

    GLAH
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.